Literature DB >> 8485727

Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: reciprocal regulation of cell cycle-controlled and bone-related genes.

F M van den Ent1, A J van Wijnen, T J Last, R Bortell, J L Stein, J B Lian, G S Stein.   

Abstract

Cell density-induced growth inhibition of osteosarcoma cells (ROS 17/2.8) results in the shutdown of proliferation-specific histone H4 and H2B genes and the concomitant up-regulation of several osteoblast-related genes. In several respects, this reciprocal regulatory relationship is analogous to the proliferation/differentiation transition stage during development of the bone cell phenotype in normal diploid osteoblasts. Here, we comprehensively analyzed the promoter binding activities interfacing with key regulatory elements in the cell cycle-dependent histone and bone-specific osteocalcin genes. Similarly, we examined factors interacting with a series of general transcription regulatory elements that are present in a broad spectrum of promoters. The results show that histone promoter binding activities HiNF-D, HiNF-P/H4TF-2, H4UA-1, and OCT-1, as well as AP-1 activity, are proliferation dependent. These factors decline coordinately during the cessation of proliferation in both ROS 17/2.8 bone tumor cells and normal diploid osteoblasts. Collective down-regulation of these trans-activating factors occurs in both cell types within the physiological context of constitutive regulation of ubiquitous transcription factors (Sp1, ATF, and CCAAT binding proteins). In addition, during growth inhibition of ROS 17/2.8 cells we observe a complex series of modifications in protein/DNA interactions of the osteocalcin gene. These modifications include both increased and decreased representation of promoter factor complexes occurring at steroid hormone response elements as well as tissue-specific basal promoter sequences. These results demonstrate cell growth regulation of the promoter factors binding to the proliferation-specific histone and tissue-specific osteocalcin genes during the cessation of proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485727

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Identification of HiNF-P, a key activator of cell cycle-controlled histone H4 genes at the onset of S phase.

Authors:  Partha Mitra; Rong-Lin Xie; Ricardo Medina; Hayk Hovhannisyan; S Kaleem Zaidi; Yue Wei; J Wade Harper; Janet L Stein; André J van Wijnen; Gary S Stein
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

2.  The integrated activities of IRF-2 (HiNF-M), CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription of a cell cycle controlled human histone H4 gene: mechanistic differences between distinct H4 genes.

Authors:  F Aziz; A J van Wijnen; P S Vaughan; S Wu; A R Shakoori; J B Lian; K J Soprano; J L Stein; G S Stein
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

3.  CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.

Authors:  A J van Wijnen; M F van Gurp; M C de Ridder; C Tufarelli; T J Last; M Birnbaum; P S Vaughan; A Giordano; W Krek; E J Neufeld; J L Stein; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 4.  The architectural organization of human stem cell cycle regulatory machinery.

Authors:  Gary S Stein; Janet L Stein; Andre van J Wijnen; Jane B Lian; Martin Montecino; Ricardo Medina; Kristie Kapinas; Prachi Ghule; Rodrigo Grandy; Sayyed K Zaidi; Klaus A Becker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Delineation of a human histone H4 cell cycle element in vivo: the master switch for H4 gene transcription.

Authors:  A Ramsey-Ewing; A J Van Wijnen; G S Stein; J L Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Transcription of histone H4, H3, and H1 cell cycle genes: promoter factor HiNF-D contains CDC2, cyclin A, and an RB-related protein.

Authors:  A J van Wijnen; F Aziz; X Graña; A De Luca; R K Desai; K Jaarsveld; T J Last; K Soprano; A Giordano; J B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 7.  The abbreviated pluripotent cell cycle.

Authors:  Kristina Kapinas; Rodrigo Grandy; Prachi Ghule; Ricardo Medina; Klaus Becker; Arthur Pardee; Sayyed K Zaidi; Jane Lian; Janet Stein; Andre van Wijnen; Gary Stein
Journal:  J Cell Physiol       Date:  2013-01       Impact factor: 6.384

8.  Role of diabetes- and obesity-related protein in the regulation of osteoblast differentiation.

Authors:  Gabriel R Linares; Weirong Xing; Hans Burghardt; Bernhard Baumgartner; Shin-Tai Chen; Wifredo Ricart; José Manuel Fernández-Real; Antonio Zorzano; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-05       Impact factor: 4.310

9.  Transcriptional activation of the histone nuclear factor P (HiNF-P) gene by HiNF-P and its cyclin E/CDK2 responsive co-factor p220NPAT defines a novel autoregulatory loop at the G1/S phase transition.

Authors:  Rong-Lin Xie; Lijun Liu; Partha Mitra; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Gene       Date:  2007-08-09       Impact factor: 3.688

10.  Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.

Authors:  Li Shijie; Pan Zhen; Qin Kang; Guo Hua; Yang Qingcheng; Cheng Dongdong
Journal:  Clin Transl Med       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.